MEDX ETF — Horizon Kinetics Medical ETF

Horizon Kinetics Medical ETF (MEDX)

Updated October 16, 2026.

MEDX is an ETF. its distribution rate is 1.14%, its trailing-12-month yield is 1.14%, its expense ratio is 0.85%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 25.8% over the past 3.7 years, 71.1 points behind SPY at 96.9%.

Horizon Kinetics Medical ETF is an actively-managed equity ETF that invests at least eighty percent of its assets in common stocks, convertible securities, and other equity securities of U.S. and foreign companies in medical research, pharmaceuticals, medical technology, and related technology industries. The fund carries an expense ratio of 0.85% and distributes annually at a modest current rate. It may appeal to investors seeking exposure to medical and healthcare innovation with an active management approach.

MEDX performance versus SPY

Price and return data through 2026-10-16.

Total return is 25.8% over the past 3.7 years, 71.1 points behind SPY at 96.9%. Over the past year its total return — price change plus distributions reinvested — is 16.1%. Its deepest 1-year drawdown was 10.5%.

MEDX key facts

Distribution Safety Score™

50 · Unproven

Issuer

Horizon Kinetics

Asset type

ETF

Asset class

Equity

Inception date

09/30/1999

Expense ratio

0.85%

Distribution rate

1.14%

Distribution frequency

Annual

Trailing yield

1.14%

Last close

$36.00 (as of 2026-10-16)

AUM

$16,583,698

Average volume

57.0

Dividend

$0.409

Ex-dividend date

12/23/2025

Payment date

12/24/2025

Beta

0.58

How Dividend Vision calculates yield and returns

Distribution rate (1.14%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (1.14%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: Horizon Kinetics; prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

MEDX risks and drawbacks

MEDX's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 10.5%.

Who may consider MEDX — and who may not

It is a weaker fit for investors who need monthly cash flow (MEDX pays annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on MEDX

• All tickers starting with M

Frequently asked questions

More securities from Horizon Kinetics.